CN1299770C - 多功能鼻腔和鼻窦洁疗液 - Google Patents
多功能鼻腔和鼻窦洁疗液 Download PDFInfo
- Publication number
- CN1299770C CN1299770C CNB2004100242204A CN200410024220A CN1299770C CN 1299770 C CN1299770 C CN 1299770C CN B2004100242204 A CNB2004100242204 A CN B2004100242204A CN 200410024220 A CN200410024220 A CN 200410024220A CN 1299770 C CN1299770 C CN 1299770C
- Authority
- CN
- China
- Prior art keywords
- factor
- clean
- nasal cavity
- nasal
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000003928 nasal cavity Anatomy 0.000 title claims abstract description 97
- 239000007788 liquid Substances 0.000 title claims abstract description 73
- 210000003695 paranasal sinus Anatomy 0.000 title claims abstract description 57
- 238000002560 therapeutic procedure Methods 0.000 title claims description 61
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003792 electrolyte Substances 0.000 claims abstract description 19
- 241000894006 Bacteria Species 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 238000009455 aseptic packaging Methods 0.000 claims abstract description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 210000002850 nasal mucosa Anatomy 0.000 claims description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- 239000000872 buffer Substances 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- 239000000043 antiallergic agent Substances 0.000 claims description 9
- 239000000460 chlorine Substances 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 239000006041 probiotic Substances 0.000 claims description 9
- 230000000529 probiotic effect Effects 0.000 claims description 9
- 235000018291 probiotics Nutrition 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 7
- 239000012286 potassium permanganate Substances 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 102000016943 Muramidase Human genes 0.000 claims description 6
- 108010014251 Muramidase Proteins 0.000 claims description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 6
- 230000000840 anti-viral effect Effects 0.000 claims description 6
- 230000009286 beneficial effect Effects 0.000 claims description 6
- 239000004325 lysozyme Substances 0.000 claims description 6
- 229960000274 lysozyme Drugs 0.000 claims description 6
- 235000010335 lysozyme Nutrition 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- 229940090898 Desensitizer Drugs 0.000 claims description 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 239000000645 desinfectant Substances 0.000 claims description 4
- 229960001680 ibuprofen Drugs 0.000 claims description 4
- 239000008247 solid mixture Substances 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000003204 osmotic effect Effects 0.000 claims description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical group OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims description 2
- 206010035664 Pneumonia Diseases 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 229960003291 chlorphenamine Drugs 0.000 claims description 2
- 239000012531 culture fluid Substances 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 12
- 238000004140 cleaning Methods 0.000 abstract description 11
- 239000002994 raw material Substances 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 6
- 206010039083 rhinitis Diseases 0.000 abstract description 5
- 230000000172 allergic effect Effects 0.000 abstract description 4
- 208000010668 atopic eczema Diseases 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000000474 nursing effect Effects 0.000 abstract description 4
- 239000003242 anti bacterial agent Substances 0.000 abstract description 3
- 229940088710 antibiotic agent Drugs 0.000 abstract description 3
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 3
- 230000003266 anti-allergic effect Effects 0.000 abstract description 2
- 239000006172 buffering agent Substances 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 210000001331 nose Anatomy 0.000 description 8
- 206010020751 Hypersensitivity Diseases 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000028327 secretion Effects 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- LIYAPIFCZOVGQS-UHFFFAOYSA-N [Na].[Cl].[K] Chemical compound [Na].[Cl].[K] LIYAPIFCZOVGQS-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 201000009890 sinusitis Diseases 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 102000006395 Globulins Human genes 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000304 virulence factor Substances 0.000 description 2
- 230000007923 virulence factor Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 241001417527 Pempheridae Species 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000010352 nasal breathing Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100242204A CN1299770C (zh) | 2004-05-31 | 2004-05-31 | 多功能鼻腔和鼻窦洁疗液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100242204A CN1299770C (zh) | 2004-05-31 | 2004-05-31 | 多功能鼻腔和鼻窦洁疗液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1583172A CN1583172A (zh) | 2005-02-23 |
CN1299770C true CN1299770C (zh) | 2007-02-14 |
Family
ID=34600833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100242204A Expired - Lifetime CN1299770C (zh) | 2004-05-31 | 2004-05-31 | 多功能鼻腔和鼻窦洁疗液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1299770C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016074692A (ja) * | 2014-10-07 | 2016-05-12 | 勝詮 中山 | 花粉症の症状を激症化させて花粉症を完治させるための剤 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100384435C (zh) * | 2005-10-25 | 2008-04-30 | 卢育华 | 一种治疗鼻腔疾病的盐水药液及应用装置 |
CN102204926A (zh) * | 2011-05-31 | 2011-10-05 | 江苏富林医疗设备有限公司 | 鼻腔清洗剂 |
CN105902555A (zh) * | 2016-06-22 | 2016-08-31 | 张波 | 一种新型洗鼻组合剂及其制备方法 |
CN107899006A (zh) * | 2017-11-28 | 2018-04-13 | 四川清舒乐科技有限公司 | 冲洗鼻腔的药物组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN87108340A (zh) * | 1986-12-16 | 1988-07-13 | 洛沃工业公司 | 鼻用药配方及其制备方法 |
CN1031940A (zh) * | 1987-09-14 | 1989-03-29 | 洛沃工业公司 | 通过粘膜给药的配方及其制备方法 |
CN1545944A (zh) * | 2003-12-08 | 2004-11-17 | 孙善伟 | 一种含有糖、电解质和微量元素的运动饮料 |
-
2004
- 2004-05-31 CN CNB2004100242204A patent/CN1299770C/zh not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN87108340A (zh) * | 1986-12-16 | 1988-07-13 | 洛沃工业公司 | 鼻用药配方及其制备方法 |
CN1031940A (zh) * | 1987-09-14 | 1989-03-29 | 洛沃工业公司 | 通过粘膜给药的配方及其制备方法 |
CN1545944A (zh) * | 2003-12-08 | 2004-11-17 | 孙善伟 | 一种含有糖、电解质和微量元素的运动饮料 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016074692A (ja) * | 2014-10-07 | 2016-05-12 | 勝詮 中山 | 花粉症の症状を激症化させて花粉症を完治させるための剤 |
Also Published As
Publication number | Publication date |
---|---|
CN1583172A (zh) | 2005-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tablan et al. | Guidelines for preventing healthcare-associated pneumonia, 2003 | |
US5897872A (en) | Iodine-containing nasal moisturizing saline solution | |
CN103285028B (zh) | 一种壳聚糖和有机硅季铵盐复合抗菌剂及制备方法 | |
CN1302183A (zh) | 用于治疗上呼吸道病症的木糖醇组合物 | |
CN102657611B (zh) | 丙酮酸钠鼻喷剂及其制备方法 | |
CN108077311A (zh) | 一种防雾霾的抗菌喷剂及其制备方法和用途 | |
CN107899006A (zh) | 冲洗鼻腔的药物组合物及其制备方法 | |
CN1299770C (zh) | 多功能鼻腔和鼻窦洁疗液 | |
CN108391673A (zh) | 一种纳米银/季铵盐复合消毒剂的制备方法 | |
CN114606767B (zh) | 一种广谱抗菌聚丙烯无纺布的制备方法 | |
JP2019532991A (ja) | バイオフィルムの制御のための材料および方法 | |
CN105412913B (zh) | 一种鼻腔润湿剂 | |
CN105381454B (zh) | 一种含海藻糖的鼻腔润湿剂 | |
CN105920094A (zh) | 一种鼻腔护理组合物、其用途以及所得的鼻腔护理产品 | |
CN101094896A (zh) | 氢氧化钙的新用途 | |
TW202200120A (zh) | 鼻內給藥的聚合性組合物 | |
El-Ansary et al. | Control of antibiotic resistance and superinfections as a strategy to manage COVID-19 deaths | |
RU2341273C1 (ru) | Способ лечения стафилококкового бактерионосительства в носоглотке | |
US11602541B2 (en) | Nasal spray composition | |
WO2023281272A1 (en) | Nasal spray | |
CN1534068A (zh) | 纳米抗菌涂料的配方和生产工艺 | |
CN1628695A (zh) | 一种含透明质酸及其盐的洗眼液及其制作方法 | |
Eggimann et al. | Nonantibibiotic measures for the prevention of Gram‐positive infections | |
CN1817369A (zh) | 多用途空气抑菌抗菌增新剂 | |
CN1325680A (zh) | 鼻和鼻咽腔清洗液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANG LIWEN Free format text: FORMER OWNER: LIU JINZHOU Effective date: 20091225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091225 Address after: Jiangsu province Wuxi City Dongting Road edseveral garden 44 room unit 402 zip code: 214101 Patentee after: Zhang Liwen Address before: Ji'nan City, Shandong Province, No. ten East Road 1, Century City District 7 building, Ji'nan XinDa patent office, Liu Zhou Zhou zip code: 250014 Co-patentee before: Zhang Lixin Patentee before: Liu Jinzhou |
|
ASS | Succession or assignment of patent right |
Owner name: ZHANG LIXIN Free format text: FORMER OWNER: ZHANG LIWEN Effective date: 20110111 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 214101 ROOM 402, UNIT 44, SEVILLA HOLIDAY GARDEN, DONGTING MIDDLE ROAD, WUXI CITY, JIANGSU PROVINCE TO: 225316 G09, NO. 1, YAOCHENG AVENUE, TAIZHOU CITY, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110111 Address after: 225316, G09, 1 drug City Avenue, Jiangsu, Taizhou Patentee after: Zhang Lixin Address before: 214101 Jiangsu Province, Wuxi City Dongting Road edseveral garden 44 unit 402 room Patentee before: Zhang Liwen |
|
ASS | Succession or assignment of patent right |
Owner name: JIANGSU TECHWORLD MEDICALS CO., LTD. Free format text: FORMER OWNER: ZHANG LIXIN Effective date: 20111115 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20111115 Address after: 225316, G09, 1 drug City Avenue, Jiangsu, Taizhou Patentee after: JIANGSU TECHWORLD MEDICAL CO.,LTD. Address before: 225316, G09, 1 drug City Avenue, Jiangsu, Taizhou Patentee before: Zhang Lixin |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 225316, G09, 1 drug City Avenue, Jiangsu, Taizhou Patentee after: JIANGSU TECHWORLD MEDICAL CO.,LTD. Address before: 225316, G09, 1 drug City Avenue, Jiangsu, Taizhou Patentee before: JIANGSU TECHWORLD MEDICAL CO.,LTD. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20070214 |